Skip to main content

Editorial: Licensing and Use of New Therapies in MS: Where Are We Going?

Publication ,  Journal Article
Hurwitz, B
Published in: Int MS J
August 2005

Duke Scholars

Published In

Int MS J

ISSN

1352-8963

Publication Date

August 2005

Volume

12

Issue

2

Start / End Page

39 / 41

Location

England

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Neurology & Neurosurgery
  • Natalizumab
  • Multiple Sclerosis
  • Licensure
  • Interferon-beta
  • Interferon beta-1a
  • Humans
  • Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurwitz, Barrie. “Editorial: Licensing and Use of New Therapies in MS: Where Are We Going?Int MS J 12, no. 2 (August 2005): 39–41.
Hurwitz, Barrie. “Editorial: Licensing and Use of New Therapies in MS: Where Are We Going?Int MS J, vol. 12, no. 2, Aug. 2005, pp. 39–41.

Published In

Int MS J

ISSN

1352-8963

Publication Date

August 2005

Volume

12

Issue

2

Start / End Page

39 / 41

Location

England

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Neurology & Neurosurgery
  • Natalizumab
  • Multiple Sclerosis
  • Licensure
  • Interferon-beta
  • Interferon beta-1a
  • Humans
  • Health Services